Market Research Logo

Microbubbles / Ultrasound Contrast Agents Market– Global Opportunity Analysis And Industry Forecast (2018-2024)

Microbubbles/Ultrasound Contrast Agents Market by Therapeutic Area (Cardiovascular diseases, Renal and associated diseases, and others), by Application (Molecular Imaging, Gene Therapy, Drug Delivery, and Stem Cells Delivery) - Global Opportunity Analysis and Industry Forecasts to 2024 Global Microbubbles/Ultrasound Contrast Agents Market is expected to reach USD 1,584.5 million by 2024, at a CAGR of 25.2% during the forecast period of 2018 to 2024. Succeeding an extensive secondary and primary research on microbubbles/ultrasound contrast agents and in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, opportunities, and trends in the market dynamics segment. Advancement in ultrasound technologies, benefits over alternative technologies, favorable reimbursement policies for contrast enhanced procedures in the U.S., increase in demand for diagnostics & image guided procedures, and growing aging population and subsequent rise in the prevalence of chronic diseases are majorly driving the microbubbles/ultrasound contrast agents market. However, factors such as complexity involved in conducting contrast enhanced ultrasound (CEUS) procedures retard the growth of this market. In addition, the report further gives an extensive outlook on microbubbles/ultrasound contrast agents market with respect to various therapeutic areas and applications. An in-depth analysis of the geographic scenario of the industry provides detailed qualitative and quantitative insights for the major geographies (North America, Europe, Asia-Pacific, and rest of the World). The geographic analysis provides detailed insights on the key trends of the industry in the listed regions, identifying the demographic & economic impact, and government & private investments. The report identifies North America to be the largest market followed by Europe, Asia Pacific, and Rest of World. The geographic analysis section also comments on the key market players shaping the growth of the industry in the respective regions. The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2014-2017). The key players in the global microbubbles/ultrasound contrast agents market are Lantheus Holdings, Inc., Bracco, GE Healthcare, Daiichi Sankyo Company, Limited, and nanoPET Pharma GmbH. Scope of the report Market by Therapeutic Area: • Cardiovascular diseases • Renal and associated diseases • Others Market by Application: • Molecular imaging • Gene therapy • Drug delivery • Stem cells delivery Market by Geography: • North America • Europe • Asia-Pacific (APAC) • Rest of the World


Microbubbles / Ultrasound Contrast Agents Market– Global Opportunity Analysis And Industry Forecast (2018-2024)

Microbubbles/Ultrasound Contrast Agents Market by Therapeutic Area (Cardiovascular diseases, Renal and associated diseases, and others), by Application (Molecular Imaging, Gene Therapy, Drug Delivery, and Stem Cells Delivery) - Global Opportunity Analysis and Industry Forecasts to 2024

Global Microbubbles/Ultrasound Contrast Agents Market is expected to reach USD 1,584.5 million by 2024, at a CAGR of 25.2% during the forecast period of 2018 to 2024.

Succeeding an extensive secondary and primary research on microbubbles/ultrasound contrast agents and in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, opportunities, and trends in the market dynamics segment. Advancement in ultrasound technologies, benefits over alternative technologies, favorable reimbursement policies for contrast enhanced procedures in the U.S., increase in demand for diagnostics & image guided procedures, and growing aging population and subsequent rise in the prevalence of chronic diseases are majorly driving the microbubbles/ultrasound contrast agents market. However, factors such as complexity involved in conducting contrast enhanced ultrasound (CEUS) procedures retard the growth of this market.

In addition, the report further gives an extensive outlook on microbubbles/ultrasound contrast agents market with respect to various therapeutic areas and applications. An in-depth analysis of the geographic scenario of the industry provides detailed qualitative and quantitative insights for the major geographies (North America, Europe, Asia-Pacific, and rest of the World). The geographic analysis provides detailed insights on the key trends of the industry in the listed regions, identifying the demographic & economic impact, and government & private investments. The report identifies North America to be the largest market followed by Europe, Asia Pacific, and Rest of World. The geographic analysis section also comments on the key market players shaping the growth of the industry in the respective regions.

The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 4 years (2014-2017).

The key players in the global microbubbles/ultrasound contrast agents market are Lantheus Holdings, Inc., Bracco, GE Healthcare, Daiichi Sankyo Company, Limited, and nanoPET Pharma GmbH.

Scope of the report

Market by Therapeutic Area:


Cardiovascular diseases
Renal and associated diseases
Others

Market by Application:

Molecular imaging
Gene therapy
Drug delivery
Stem cells delivery

Market by Geography:

North America
Europe
Asia-Pacific (APAC)
Rest of the World

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report